Venture capitalist abandons effort to create Minnesota early stage fund(?)

Fund founder Jim O’Reilly says it was “fairly impossible” to raise money. For O’Reilly, explaining Upwind to potential investors proved to be a challenge in itself. For one thing, O’Reilly insisted Upwind was not a “fund” but rather a “new model” for developing startups.

[Read more of this report]


Coordinate Capital mum on Minnesota biotech fund

Steve Burrill may have trouble keeping quiet about the proposed $1 billion fund to back the Elk Run BioBusiness Park, but at least one Burrill-related fund in Minnesota has largely remained silent on its plans. Coordinate Capital LLC has been trying to raise a $25 million local fund to invest in biomass, energy and life science startups. Ten months later, CEO and managing partner Andrew Pulkrabek has stuck to its guns — by not saying anything. Which is not necessarily a bad thing.

[Read more of this report]


Minnesota investors: Still waiting….after all of these years

If patience is a virtue, then Minnesota venture capitalists have become downright saintly.Faced with a weak economy that has stifled initial public offerings and mergers and acquisitions, local investors are still looking for exits well after the funds have closed. Throw in tougher regulatory scrutiny for medical devices and drugs and an exit can suddenly [...]

[Read more of this report]


Upwind Medical Partners to create $8 million early stage fund

Another day, another new local early stage fund.Upwind Medical Partners is launching a $6 million to $8 million early stage fund that will focus on commercializing intellectual property from health care/research institutions like the University of Minnesota, Wisconsin Alumni Research Fund (WARF), Allina Hospitals & Clinics, and John Hopkins Hospital in Baltimore.Founded by Jim O’Reilly, [...]

[Read more of this report]


Affinity Capital and Triathlon Medical Ventures plan new $10M early stage fund in Minnesota

Affinity’s fund is not tied to a specific incubator, which means the firm will cast a larger net for start-ups. Given its history of investing exclusively in late stage companies, Affinity’s move could provide Minnesota’s early stage entrepreneurs a real shot in the arm.

[Read more of this report]


New Minnesota biotech fund seeks $25 million with a little help from Steve Burrill and yours truly

Burrill is having trouble finding local money for the $500 million of the Elk Run fund that will purchase direct equity stakes in start-ups housed at the planned Elk Run Biosciences Center. So it’s no surprise that Coordinate is trying to appeal to the state’s sense of economic pride.

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics